Pfizer (PFE) Property, Plant & Equipment (Net) (2009 - 2026)

Pfizer (PFE) Property, Plant & Equipment (Net) (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PP&E (Net) (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn 12.59 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn 26.54 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 23.27 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn 5.69 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn 25.43 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn 8.22 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn 5.64 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn 19.40 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn 7.66 Bn
10 Novartis Ag 108.28 Bn 107.60 Bn - -

Historic Data

Download Data
DateValue
Mar 29, 2026 19.40 Bn
Mar 29, 2026 19.40 Bn
Dec 31, 2025 19.32 Bn
Dec 31, 2025 19.32 Bn
Sep 28, 2025 18.88 Bn
Sep 28, 2025 18.88 Bn
Jun 29, 2025 18.78 Bn
Jun 29, 2025 18.78 Bn
Mar 30, 2025 18.35 Bn
Mar 30, 2025 18.35 Bn
Dec 31, 2024 18.39 Bn
Dec 31, 2024 18.39 Bn
Sep 29, 2024 18.54 Bn
Sep 29, 2024 18.54 Bn
Jun 30, 2024 18.96 Bn
Jun 30, 2024 18.96 Bn
Mar 31, 2024 18.80 Bn
Mar 31, 2024 18.80 Bn
Dec 31, 2023 18.94 Bn
Dec 31, 2023 18.94 Bn